A Systems Approach Implicates a Brain Mitochondrial Oxidative Homeostasis Co-expression Network in Genetic...

Area of Science:

• Neurogenetics
• Pharmacology
• Mitochondrial Biology

Background:

• Genetic factors significantly influence vulnerability to alcohol dependence (alcoholism).
• Previous studies identified quantitative trait loci (QTLs) on mouse chromosome 1 (Alcdp1 and Alcw1) affecting alcohol dependence and withdrawal.
• These QTLs are located in a region syntenic with human 1q23.2-23.3 and show genetic variation between C57BL/6J and DBA/2J mouse strains.

Purpose of the Study:

• To create and characterize a novel congenic mouse model (R2) to study the genetic basis of alcohol withdrawal.
• To investigate gene expression patterns associated with alcohol withdrawal severity using Weighted Gene Co-expression Network Analysis (WGCNA).
• To evaluate the therapeutic potential of N-acetylcysteine in reducing alcohol withdrawal symptoms.

Main Methods:

• Development of a recombinant congenic mouse model (R2) by introgressing the Alcw1/Alcdp1 interval from C57BL/6J onto a DBA/2J background.
• Assessment of alcohol withdrawal severity in R2 mice compared to wild-type littermates.
• Microarray and quantitative PCR analyses to assess gene expression in the Alcw1/Alcdp1 interval.
• Weighted Gene Co-expression Network Analysis (WGCNA) using reciprocal congenic models.
• Administration of N-acetylcysteine to assess its effect on alcohol withdrawal symptoms.

Main Results:

• R2 congenic mice exhibited significantly less severe alcohol withdrawal symptoms compared to wild-type DBA/2J mice.
• WGCNA identified co-expression modules common to both genetic backgrounds, including genes involved in oxidative phosphorylation.
• Administration of N-acetylcysteine significantly reduced alcohol withdrawal-induced convulsions in mice.

Conclusions:

• The Alcw1/Alcdp1 genetic interval plays a crucial role in modulating alcohol withdrawal severity.
• Mitochondrial oxidative phosphorylation is implicated in alcohol use disorders (AUDs).
• N-acetylcysteine demonstrates therapeutic potential for managing alcohol withdrawal symptoms, highlighting the importance of mitochondrial oxidative homeostasis.